| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/18/2007 | WO2007054623A2 Mammalian hedgehog signaling inhiabitors |
| 05/18/2007 | WO2007054580A1 N-sulfamoyl-n’-benzopyranpiperidines as inhbitors of carbonic anhydrases |
| 05/18/2007 | WO2007054579A1 Staurosporine derivatives for use in alveolar rhabdomyosarcoma |
| 05/18/2007 | WO2007054573A2 Anti-proliferative combination therapy comprising a platinum-based chemotherapeutic agent and egfr inhibitors or pyrimidine analogues |
| 05/18/2007 | WO2007054556A1 Novel pyridopyrazines and their use as modulators of kinases |
| 05/18/2007 | WO2007054551A1 Combination treatment of cancer comprising egfr/her2 inhibitors |
| 05/18/2007 | WO2007054550A1 Quinazoline derivatives for the treatment of cancer diseases |
| 05/18/2007 | WO2007054508A1 Pyrrolopyridines as kinase inhibitors |
| 05/18/2007 | WO2007054373A1 Composition and its use for the manufacture of a medicament for treating, prophylactically treating, preventing cancer and/or infections in the urinary tract |
| 05/18/2007 | WO2007054357A1 Thiazole analogues and uses thereof |
| 05/18/2007 | WO2007054292A2 Azonafide derivatives, methods for their production and pharmaceutical compositions therefrom |
| 05/18/2007 | WO2007054138A1 Substituted tetrahydroquinolines |
| 05/18/2007 | WO2007054128A1 Novel inhibitors of the lfa-1/icam-1 interaction, and uses thereof |
| 05/18/2007 | WO2007054120A1 Identification and characterization of function-blocking anti-ed-b-fibronectin antibodies |
| 05/18/2007 | WO2007054030A1 Polyethylene glycol modifications of thymosin alpha-1 |
| 05/18/2007 | WO2007053956A1 Cancer antigen mage-a9 and uses thereof |
| 05/18/2007 | WO2007053912A1 Use of angeloyl-substituted ingenanes in combination with other agents to treat cancer |
| 05/18/2007 | WO2007035841A9 Analogs of dehydrophenylahistins and their therapeutic use |
| 05/18/2007 | WO2007033140A3 Prok2 antagonists and methods of use |
| 05/18/2007 | WO2007031853A3 Therapeutic combination of hamlet and a hdac inhibitor to treat cancer |
| 05/18/2007 | WO2007031833A3 Novel series of imidazolyl substituted steroidal and indan-1-one derivatives |
| 05/18/2007 | WO2007030680A3 Triazole derivatives useful as axl inhibitors |
| 05/18/2007 | WO2007029035A3 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
| 05/18/2007 | WO2007023073A3 Bicyclic heterocycles medicaments comprising said compounds use and method for production thereof |
| 05/18/2007 | WO2007017695A3 Dihydroxyanthraquinones and their use |
| 05/18/2007 | WO2007013944A3 Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders |
| 05/18/2007 | WO2007013556A8 Composition for prevention of cancer |
| 05/18/2007 | WO2007011647A3 Inhibitors of mitotic kinesin ksp |
| 05/18/2007 | WO2007006544A3 Cyclic adenosine monophosphate compounds for the treatment of immune-related disorders |
| 05/18/2007 | WO2007003944A3 Compounds for imaging and therapy |
| 05/18/2007 | WO2007000601A3 Gene regulation |
| 05/18/2007 | WO2006132907A3 Methods of treating, diagnosing or detecting cancer using an ephb3 modulator |
| 05/18/2007 | WO2006125555A3 Quinazolinones |
| 05/18/2007 | WO2006119395A3 Combination of a beta-glucan and an egf receptor antagonist for the treatment of cancer and infection |
| 05/18/2007 | WO2006106438A3 Modulators of ppar activity |
| 05/18/2007 | WO2006036278A8 THERAPEUTIC AGENTS TARGETING THE NCCa-ATP CHANNEL AND METHODS OF USE THEREOF |
| 05/18/2007 | WO2006029487A8 Platelet factor 4 variant 1 (pf4var1) related inhibitors of angiogenesis |
| 05/18/2007 | WO2006020719A3 Aminoacid conjugates of beta - lapachone for tumor targeting |
| 05/18/2007 | WO2003076594A3 Genomic screen for epigenetically silenced tumor suppressor genes |
| 05/18/2007 | CA2833852A1 Quinazoline derivatives for the treatment of cancer diseases |
| 05/18/2007 | CA2833706A1 Quinazoline derivatives for the treatment of cancer diseases |
| 05/18/2007 | CA2630023A1 Cancer antigen mage-a9 and uses thereof |
| 05/18/2007 | CA2629864A1 N-sulfamoyl-n'-benzopyranpiperidines as inhbitors of carbonic anhydrases |
| 05/18/2007 | CA2629770A1 Thiazole analogues and uses thereof |
| 05/18/2007 | CA2629478A1 Staurosporine derivatives for use in alveolar rhabdomyosarcoma |
| 05/18/2007 | CA2629376A1 Inhibitors of parp activity and uses thereof |
| 05/18/2007 | CA2629337A1 Use of angeloyl-substituted ingenanes in combination with other agents to treat cancer |
| 05/18/2007 | CA2629298A1 Anti-proliferative combination therapy comprising a platinum-based chemotherapeutic agent and egfr inhibitors or pyrimidine analogues |
| 05/18/2007 | CA2629258A1 Azonafide derivatives, methods for their production and pharmaceutical compositions therefrom |
| 05/18/2007 | CA2629249A1 Combination treatment of cancer comprising egfr/her2 inhibitors |
| 05/18/2007 | CA2629244A1 Quinazoline derivatives for the treatment of cancer diseases |
| 05/18/2007 | CA2629228A1 Pyrrolopyridines as kinase inhibitors |
| 05/18/2007 | CA2628624A1 Indole derivatives as antitumoural compounds |
| 05/18/2007 | CA2628552A1 Identification and characterization of function-blocking anti-ed-b-fibronectin antibodies |
| 05/18/2007 | CA2628534A1 Methods for inhibiting protein kinases |
| 05/18/2007 | CA2628039A1 Novel pyridopyrazines and their use as modulators of kinases |
| 05/18/2007 | CA2627923A1 Histone deacetylase (hdac) inhibitors (pxdlol) for the treatment of cancer |
| 05/18/2007 | CA2626897A1 Histone deacetylase inhibitors with aryl-pyrazolyl motifs |
| 05/18/2007 | CA2626479A1 Protein kinase inhibitors |
| 05/18/2007 | CA2624905A1 Pqs and its conjugates as adjuvants and their uses in pharmaceutical compositions |
| 05/18/2007 | CA2624903A1 Cyclic-dinucleotides and its conjugates as adjuvants and their uses in pharmaceutical compositions |
| 05/18/2007 | CA2611889A1 Substituted tetrahydroquinolines |
| 05/18/2007 | CA2608726A1 Inhibitors of vegf receptor and hgf receptor signaling |
| 05/18/2007 | CA2537783A1 Tumour treatment |
| 05/17/2007 | US20070112205 Cyanopyrrolidine derivatives |
| 05/17/2007 | US20070112179 Novel compounds |
| 05/17/2007 | US20070112176 Lipid membrane structure containing anti-mt-mmp monoclonal antibody |
| 05/17/2007 | US20070112175 Determining drug resistance |
| 05/17/2007 | US20070112061 Heat- or singlet oxygen-generating agents and cancer treatment compositions comprising organic peroxide or chemiluminescent compound |
| 05/17/2007 | US20070112059 Cyanopyrrolidine derivatives |
| 05/17/2007 | US20070112046 2'-Methyl-5'-(1,3,4-Oxadiazol-2-yl)-1,1'-Biphenyl-4-Carboxamide Derivatives and Their Use As P38 Kinase Inhibitors |
| 05/17/2007 | US20070112044 Antitumor, anticancer agents; using a 2-amino-5-phenyl-(1,3,4)thiadiazole compound |
| 05/17/2007 | US20070112028 2-Hydroxymethyl-3,4,5-trihydroxy-1-benzilpiperidine derivatives as inhibitors of glucosylceramide |
| 05/17/2007 | US20070112008 Saframycins, analogues and uses thereof |
| 05/17/2007 | US20070111967 Organosilicon compounds and their use |
| 05/17/2007 | US20070111956 Remedy for sarcoidosis and method of treating the same |
| 05/17/2007 | US20070111946 Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP) |
| 05/17/2007 | US20070111945 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action |
| 05/17/2007 | US20070111942 For detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 05/17/2007 | US20070111266 Antibodies to murine zcytor17 ligand |
| 05/17/2007 | US20070110835 Method for the production of enriched hop extracts having combined oestrogenic and antiproliferative bioactivity |
| 05/17/2007 | US20070110800 Pharmaceutical composition having uniform drug distribution and potency |
| 05/17/2007 | US20070110753 Therapeutic agents for solid tumors |
| 05/17/2007 | US20070110745 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
| 05/17/2007 | US20070110735 administering to the heart of subject in need of increased capillary density in the heart a trk receptor ligand in an amount effective to increase capillary density in the heart, said trk receptor ligand being selected from the group consisting of brain-derived neurotrophic factor, NT-3, and NT-4. |
| 05/17/2007 | US20070110734 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs |
| 05/17/2007 | US20070110724 DNA viral plasmid for use as gene transfer tool in genetic engineering and genic therapy; improved exogenous transcriptional expression |
| 05/17/2007 | US20070110708 Silicon compounds and their use |
| 05/17/2007 | US20070110667 Radionuclide labeling of vitamin B12 and coenzymes thereof |
| 05/17/2007 | US20070108405 Compositions and methods for delivery of biologically active agents |
| 05/16/2007 | EP1785484A1 Oligonucleotide inhibiting tumor cell proliferation and method therefor |
| 05/16/2007 | EP1785423A1 Pyridopyrazine derivatives and their use as kinase modulators |
| 05/16/2007 | EP1785420A1 Thiazole analogues and uses thereof |
| 05/16/2007 | EP1785416A2 9, 10-alpha, alpha-OH-Taxane Analogs and methods for production thereof |
| 05/16/2007 | EP1785139A1 Antagonist against tolerance to anticancer drugs |
| 05/16/2007 | EP1785132A1 Constitutional function-improving agents |
| 05/16/2007 | EP1784406A1 Dihydropteridinones, process for their preparation and their use as drugs |
| 05/16/2007 | EP1784399A2 Pyrimidine derivatives |
| 05/16/2007 | EP1784397A1 5-(1,1'-biphenyl)-4-yl-5-(4-(4-aminoacylphenyl)-piperazin)-1-yl-pyrimidine-2,4,6-trione derivatives, as inhibitors of zinc metallondopeptidases, their preparation and use |
| 05/16/2007 | EP1784396A2 Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors |